keep up to date
Canadian drug importation will be heavily debated at state and federal level in 2020.
- What do Canadians think about it?
- Has it been tried before, and was it safe? Did it save money?
- Are there legal processes in place that effectively protect us from unscrupulous Canadian vendors?
Learn key facts in our 30 minute webinar:
Webinar offered at 9am Pacific / 12pm Eastern on Tue. Dec. 10, and Tue. Dec. 17. RSVP here.
PSM’s Executive Director Shabbir Safdar spoke with Dave Akerly on WILS in Lansing, Michigan about the importation proposal currently being debated in the Michigan House of Representatives. Safdar was enroute to the Michigan State House to participate in hearings on drug importation being held there. Here why our Executive Director has travelled to Michigan to testify at their drug importation hearing.
This editorial by Rosie Rivera was published in The Salt Lake Tribune on December 3, 2019. Rivera is the sheriff of Salt Lake County.
In spite of recent efforts by legislators in Florida, Maine, Colorado, and elsewhere, Canadian patient groups are vocally opposing pending legislation that proposes importing prescription medications from the Canadian drug supply. Paul Blanchard of the New Brunswick Pharmacists’ Association told CBC News, “The country’s pharmacists association has been talking to the federal government … to make sure that the federal government and Canada is aware that the Americans are literally knocking on our door.”
The recent prosecution of Jorge Nogueira and Jessyka Molina for selling counterfeit Botox wholesale highlights one of Florida’s biggest counterfeit drug problems: fake beauty injections. This is the third action against fake beauty injections in Florida in the last year.
ASOP Global and LegitScript released a report analyzing the prevalence of illicit online sales of prescription drugs in China, a country where such sales are prohibited. Their analysis showed that about half of all Chinese online pharmaceuticals sellers are illicit, potentially exposing patients to counterfeit medicines, substandard medicines, financial fraud, and identity theft…